skip to main content
Idioma:
Refinado por: materia: Cervical Cancer eliminar colección: BioMedCentral eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Material Type:
Artículo 		Añadir a Mi Portal

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Baettig, Florence ; Vlajnic, Tatjana ; Vetter, Marcus ; Glatz, Katharina ; Hench, Jürgen ; Frank, Stephan ; Bihl, Michel ; Lopez, Roberto ; Dobbie, Michael ; Heinzelmann-Schwarz, Viola ; Montavon, Céline

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.281-281, Article 281 [Revista revisada por pares]

England: BMJ Publishing Group Ltd

Texto completo disponible

Citas Citado por

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora